Sung, J.-S.; Ko, I.-G.; Hwang, L.; Kim, S.-H.; Han, J.H.; Jeon, J.W.; Kim, S.R.; Lee, J.M.; Choi, C.W.
Pirfenidone Alleviates Against Fine Particulate Matter-Induced Pulmonary Fibrosis Modulating via TGF-β1/TAK1/MKK3/p38 MAPK Signaling Pathway in Rats. Biomedicines 2025, 13, 989.
https://doi.org/10.3390/biomedicines13040989
AMA Style
Sung J-S, Ko I-G, Hwang L, Kim S-H, Han JH, Jeon JW, Kim SR, Lee JM, Choi CW.
Pirfenidone Alleviates Against Fine Particulate Matter-Induced Pulmonary Fibrosis Modulating via TGF-β1/TAK1/MKK3/p38 MAPK Signaling Pathway in Rats. Biomedicines. 2025; 13(4):989.
https://doi.org/10.3390/biomedicines13040989
Chicago/Turabian Style
Sung, Jun-Seok, Il-Gyu Ko, Lakkyong Hwang, Sang-Hoon Kim, Jin Hee Han, Jung Won Jeon, Sae Rom Kim, Jeong Mi Lee, and Cheon Woong Choi.
2025. "Pirfenidone Alleviates Against Fine Particulate Matter-Induced Pulmonary Fibrosis Modulating via TGF-β1/TAK1/MKK3/p38 MAPK Signaling Pathway in Rats" Biomedicines 13, no. 4: 989.
https://doi.org/10.3390/biomedicines13040989
APA Style
Sung, J.-S., Ko, I.-G., Hwang, L., Kim, S.-H., Han, J. H., Jeon, J. W., Kim, S. R., Lee, J. M., & Choi, C. W.
(2025). Pirfenidone Alleviates Against Fine Particulate Matter-Induced Pulmonary Fibrosis Modulating via TGF-β1/TAK1/MKK3/p38 MAPK Signaling Pathway in Rats. Biomedicines, 13(4), 989.
https://doi.org/10.3390/biomedicines13040989
